October 4, 2023
- August 23, 2023 - Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed). See NOFO RFA-AG-24-046.
National Institute on Aging (NIA)
This Notice informs potential applicants that the Key Dates information listed in Notice of Funding Opportunity (NOFO) RFA-AG-24-046, “ Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)” has changed.
The following section under Part 1. Overview Information of RFA-AG-24-046 has been modified:
Key Dates
The table currently reads:
Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/ Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| February 7, 2024 | Not Applicable | Not Applicable | June 2024 | August 2024 | September 2024 |
The table was revised to read (changes shown in bold italics):
Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/ Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| February 7, 2024 | Not Applicable | Not Applicable | June 2024 | October 2024 | November 2024 |
All other aspects of this NOFO remain unchanged.
Scientific/Research Contact(s)
Maja Maric, Ph.D.
Division of Neuroscience
National Institute in Aging (NIA)
Telephone: 301-496-9350
Email: [email protected]
Amanda DiBattista, Ph.D.
Division of Neuroscience
National Institute on Aging (NIA)
Telephone: 301-827-3342
Email: [email protected]
and Human Services (HHS)
